Theriva Biologics (TOVX) closed at $0.13 on November 19, 2026, down 11.1% from the previous close, on volume of 646,475 shares (30-day average 3,695,861).
Data as of November 19, 2026.
Theriva Biologics Stockholders Approve Key Corporate Proposals
TipRanks (Wed, 18-Nov 5:15 PM ET)
Theriva Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results
Globe Newswire (Thu, 12-Nov 8:00 AM ET)
Globe Newswire (Mon, 2-Nov 8:00 AM ET)
Globe Newswire (Wed, 30-Sep 8:00 AM ET)
Theriva Biologics’ VCN-01 Trial Shows Prolonged Survival for Resistant Head & Neck Cancer Patients
Market Chameleon (Thu, 11-Jun 6:28 AM ET)
Theriva Biologics Secures Up to $38M in SYN-020 Licensing Deal With Rasayana Therapeutics
Market Chameleon (Thu, 19-Feb 5:34 AM ET)
Market Chameleon (Mon, 29-Dec 5:32 AM ET)
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
Theriva Biologics trades on the AMEX stock market under the symbol TOVX.
As of November 19, 2026, TOVX stock price declined to $0.13 with 646,475 million shares trading.
TOVX has a beta of 1.17, meaning it tends to be more sensitive to market movements. TOVX has a correlation of 0.03 to the broad based SPY ETF.
TOVX has a market cap of $5.87 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, TOVX traded as high as $17.11 and as low as $.13.
The top ETF exchange traded funds that TOVX belongs to (by Net Assets): VXF.
TOVX has underperformed the market in the last year with a price return of -44.4% while the SPY ETF gained +9.2%. TOVX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -43.2% and -24.0%, respectively, while the SPY returned -6.7% and -2.3%, respectively.
TOVX support price is $.13 and resistance is $.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TOVX shares will trade within this expected range on the day.